9999999997-17-003239.txt : 20170315
9999999997-17-003239.hdr.sgml : 20170315
20170315145655
ACCESSION NUMBER: 9999999997-17-003239
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20170315
DATE AS OF CHANGE: 20170315
20170228
20170315
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 17690975
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-"B6UM;6U#0HQ(# @;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V4O4&%R96YT(#(@,"!2+U)E%L@," P(#8Q,B W
M.3)=("]#;VYT96YT)R56=MNVS@0?0^0?R"P+Q(0L^)5TKZESJ79W3I X@ %VL7"CN5:
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MKK.#AST^S'9HQ4]O;%*:*G KQE\H=?]P=?U ;N,\>KC$+4^F=Q.,!HE'>32^GX!_P/U7UY,IAN?N\B]B
M6/0 T6()D.ECW(4; )X(J82JS%W5:R$0.2%+
M8-AM#+;:D9?XD=D+N;^!71.6"^FU7%#F6C,0!I7) !J*%+-5I)^J$LUN
MBSB-%F8#QL85/B([D9BS;?_.4+0MGV,5-61<[^"O^8[Z")5*F@EWQ0'=42H=
M)A07@BK 2D$%.TZH/SI6N]NN*>Z*J:P%H5E7L(I&\(R<'+"
M72QD7ELL(-U$M#*9-H,4W*(/3::U)B^?X1$R#1\AVT8ZVOI)K: H"G>-9C_?
M8#J7K4WR!9G%.JK@54;;[?JP!+ZW"]85V5<+8X]O(0E%"+SC+/3@PZ(G[
M7Q<0W[E7^QC5VAWAX[E4BNH3MW)B_(0[^(;.W.-3@YN34?45]7@@H#++J.AG
M0^?4U;($CZBHLBY"9ZV)\>@.9=,X;]/K3M5"!8/,66*\0$[+"I]DM)FU)3C7
MJBTI?F"*X>SK_0+"XJ.Q@"8L=TU:[B"$]<8:8)A#KF&V+%J5AD%?>D)=%FN_6[I(P75
M1?4#P+>^Y$L4)I^#OHDM1>8[2+\]\F1FBMV(:6B^.)"$\S=;):C>E"MW4E\5
M9+E^A1W:FC;-6QA6ZF&UZA3(P;[OR-L4X(0%00^"(PRGMXT$4>:*F+Z9CPQT*_1W_
M$H%1\R\QO'Z))/S5T<7!J*ORW[(Q-0NF 5N@R]P:/SLU"DV'75>]BAH97/5Y
MW)!%T:)?=YNRLN0>V!)(Q"$UJ[JUXEJ3[7[^4B37QJT_8P&\7Y3-\[INS"=F
M;5MA*<&=:ULVT/6+LC(84WA@ LYLXEP0'/4##3XJ K"9$U8M\?E([/U4%NXF
MWF+R"719K]$,0Y$"9B%?8
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M6,>A3_%=P+(,A)6Y\_KTBV5P.LU=[)"]>*T?B.5XF1^*QP ?2)PQK
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M="]4:6UE7!E+U1R=654>7!E
M+TYA;64O1C(O0F%S949O;G0O5&EM97,C,C!.97T IGCTP!0O*YCB,V!@ !/& 9F#0IE;F1S=')E86T-"F5N9&]B
M:@T*>')E9@T*," Q,PT*,# P,# P,# P," V-34S-2!F#0HP,# P,# P,#$W
M(# P,# P(&X-"C P,# P,# P-S@@,# P,# @;@T*,# P,# P,#$S-" P,# P
M,"!N#0HP,# P,# P,S4W(# P,# P(&X-"C P,# P,#(R.#8@,# P,# @;@T*
M,# P,# P,C0V-" P,# P,"!N#0HP,# P,# R-S W(# P,# P(&X-"C P,# P
M,#(X.# @,# P,# @;@T*,# P,# P,S$Q." P,# P,"!N#0HP,# P,# S,S,S
M(# P,# P(&X-"C P,# P,#,V,S(@,# P,# @;@T*,# P,# P,SDS,R P,# P
M,"!N#0IT')E9@T*
M-#$X. T*)25%3T8-"GAR968-"C @, T*=')A:6QE<@T*/#PO4VEZ92 Q,R]2
M;V]T(#$@,"!2+TEN9F\@.2 P(%(O241;/$9#03DV,$$U14,S0C Y-# X-C%#
M,4$Y,3,Q-C)!-D)#/CQ&0T$Y-C!!-45#,T(P.30P.#8Q0S%!.3$S,38R039"
M0SY=("]0')E9@T*-#8P
(,PT*)25%3T8!
end